Auteurs
Curation
Hal
Racine
Curation
Checkpoint
Hal
Racine
Hal
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Hal)

Index « Auteurs » - entrée « Jacques Morel »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Jacques Gottenberg < Jacques Morel < Jacques Tebib  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000002 (2015) Alice Courties [France] ; Gilles Grateau [France] ; Peggy Philippe ; René-Marc Flipo [France] ; Leonardo Astudillo [France] ; Bérengère Aubry-Rozier ; Isabelle Fabreguet ; Wafki Fahd ; Olivier Fain [France] ; Pascal Guggenbuhl [France] ; Eric Hachulla [France] ; Thomas Papo [France] ; Christophe Richez [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Francis Berenbaum [France] ; Jérémie Sellam [France]AA amyloidosis treated with tocilizumab: case series and updated literature review
000015 (2019) Jacques Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
000017 (2017-11-03) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Elodie Perrodeau [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries
000033 (2016-06) Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Émilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sebastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France] ; French Society Of Dermatology And Club Rheumatisms And InflammationHidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases
000034 (2015-04) Claire Immediato Daïen [France] ; Sarah Gailhac [France] ; Rachel Audo [France] ; Thibault Mura [France] ; Michael Hahne [France] ; Bernard Combe [France] ; Jacques Morel [France]High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis
000035 (2018-01) William Terreaux ; Claire Masson [France] ; Jean-Paul Eschard ; Thomas Bardin [France] ; Arnaud Constantin [Royaume-Uni] ; Loïc Le Dantec ; Christian Marcelli [France] ; Aleth Perdriger [France] ; Claire Scotto Di Fazano ; Daniel Wendling [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Jean Salmon [France]Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE
000036 (2017-12) Yoann Ladner [France] ; Silvia Mas [France] ; Gaelle Coussot [France] ; Killian Bartley [France] ; Jérôme Montels [France] ; Jacques Morel [France] ; Catherine Perrin [France]Integrated microreactor for enzymatic reaction automation: An easy step toward the quality control of monoclonal antibodies
000052 (2017-07-14) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis [France] ; René-Marc Flipo [France] ; Stéphanie Rist [France] ; Bernard Combe [France] ; Jacques-Eric Gottenberg [France] ; Thierry Schaeverbeke [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Maxime Dougados [France] ; Alain Saraux [France] ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French registry REGATE
000054 (2018) Jean-Hugues Salmon [France] ; Jeanne-Marie Perotin [France] ; Jacques Morel [France] ; Moustapha Dramé [France] ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia [France] ; Isabelle Pane [France] ; Xavier Mariette [France] ; Jacques-Eric Gottenberg [France] ; French Society RheumatologySerious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data
000073 (2010-06) Thao Pham ; Pascal Claudepierre [France] ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel [France] ; Laure Gossec [France] ; Jacques-Eric Gottenberg ; Philippe Goupille [France] ; Severine Guillaume [France] ; Eric Hachulla [France] ; Charles Masson ; Jacques Morel [France] ; Xavier Puechal ; Alain Saraux ; Thierry Schaeverbeke [France] ; Daniel Wendling ; Eric Bruckert [France] ; Stanislas Pol [France] ; Xavier Mariette [France] ; Jean SibiliaTocilizumab therapy and safety management
000076 (2019-06-12) Kedra Joanna [France] ; Philippe Dieudé [France] ; Hubert Marotte [États-Unis] ; Alexandre Lafourcade [France] ; Emilie Ducourau [France] ; Thierry Schaeverbeke [France] ; Aleth Perdriger [France] ; Martin Soubrier [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Emmanuelle Dernis [France] ; Valérie Royant [France] ; Jean-Hugues Salmon [France] ; Thao Pham [France] ; Jacques-Eric Gottenberg [France] ; Edouard Pertuiset [France] ; Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Philippe Gaudin [France] ; Gregoire Cormier [France] ; Philippe Goupille [France] ; Xavier Mariette [France] ; Francis Berenbaum [France] ; Didier Alcaix [France] ; Sid Ahmed Rouidi [France] ; Jean-Marie Berthelot [France] ; Agnès Monnier [France] ; Christine Piroth [France] ; Frederic Liote [France] ; Vincent Goeb [France] ; Cécile Gaujoux-Viala [France] ; Isabelle Chary Valckenaere [France] ; David Hajage [France] ; Florence Tubach [France] ; Bruno Fautrel [France]Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Hal/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Hal/Curation/Author.i -k "Jacques Morel" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Hal/Curation/Author.i  \
                -Sk "Jacques Morel" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Hal
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Jacques Morel
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021